What is the prevalence of Glanzmanns thrombasthenia?

Glanzmanns thrombasthenia is an ultra-rare inherited bleeding disorder with an estimated global prevalence of approximately 1 in 1,000,000 individuals, though it is likely underdiagnosed. Because it is an autosomal recessive condition, it affects males and females with equal frequency, typically presenting with mucocutaneous bleeding symptoms from birth or early childhood.

What is the global prevalence of Glanzmanns thrombasthenia?

Determining the exact prevalence of Glanzmanns thrombasthenia is challenging due to its rarity and the potential for milder cases to remain undiagnosed. Current medical literature, including data from Orphanet, suggests a prevalence of approximately 1 per 1,000,000 people worldwide. While this classifies Glanzmanns thrombasthenia as an ultra-rare disease, the incidence is significantly higher in specific populations where consanguinity (marriage between blood relatives) is more common, as this increases the likelihood of both parents carrying the recessive gene mutation.

How does Glanzmanns thrombasthenia affect different populations and genders?

Glanzmanns thrombasthenia is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene—one from each parent—to manifest the condition. Consequently, the disease affects males and females with equal frequency. While it occurs globally, geographic clusters have been documented in populations with high rates of endogamy, such as in parts of the Middle East, South India, and among the Romani people. In these specific communities, the prevalence of Glanzmanns thrombasthenia can be much higher than the global average.

At what age does Glanzmanns thrombasthenia typically present?

The onset of Glanzmanns thrombasthenia is almost exclusively pediatric. Symptoms usually manifest shortly after birth or within early childhood. Common clinical presentations that lead to a diagnosis include:

• Epistaxis (frequent or severe nosebleeds)


• Gingival bleeding (bleeding from the gums)


• Easy bruising (purpura or ecchymosis)


• Menorrhagia (excessively heavy menstrual bleeding) in adolescent females


• Prolonged bleeding following minor trauma, dental extractions, or surgical procedures

Why is accurate data on Glanzmanns thrombasthenia difficult to obtain?

The primary challenge in establishing precise epidemiological data for Glanzmanns thrombasthenia is the risk of underdiagnosis. Many individuals with milder variants of the condition may never seek medical attention or may be misdiagnosed with other common platelet function disorders. At DiseaseMaps.org, we have seen 59 people with Glanzmanns thrombasthenia join our community to share their lived experiences. This real-world patient data helps bridge the gap between clinical statistics and the daily reality of those navigating this rare condition, providing a clearer picture of the diagnostic journey that many patients face.

Next steps

• Consult a hematologist specializing in inherited bleeding disorders to confirm a diagnosis through platelet aggregation studies or genetic testing.


• Connect with the 59 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Maintain a detailed medical alert card or wearable ID stating your diagnosis, as Glanzmanns thrombasthenia requires specialized care during emergencies or surgeries.


• Visit the NIH Genetic and Rare Diseases (GARD) Information Center for the latest clinical trial updates and resource directories.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Glanzmann thrombasthenia (ORPHA:831)


• NIH Genetic and Rare Diseases (GARD) Information Center: Glanzmann thrombasthenia


• OMIM (Online Mendelian Inheritance in Man): Glanzmann Thrombasthenia (#273800)


• World Federation of Hemophilia: Rare Bleeding Disorders guidelines